Home / Companies / CRISPR THERAPEUTICS AG / 5 Jun 2025
CRISPR THERAPEUTICS AG: meeting of 5 Jun 2025
Votes reported on Form N-PX, item by item
516 Form N-PX filers reported votes at the CRISPR THERAPEUTICS AG meeting of 5 Jun 2025. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
15 nominees; 70.1% of reported votes for; 55 filers withheld from or voted against at least one nominee.
1,939 vote records from 75 filers. 9 of the 70 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
823 vote records from 508 filers. 284 of the 473 filers that marked the item either way voted against management. 35 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
139 vote records from 74 filers. 2 of the 69 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
118 vote records from 65 filers. 0 of the 60 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
831 vote records from 80 filers. 36 of the 75 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
801 vote records from 73 filers. 0 of the 68 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
57 vote records from 17 filers. 2 of the 16 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | Against * | For |
| BlackRock and iShares | For | Against * | For |
| Fidelity | For | Against * | For |
| Dimensional | For | Against * | For |
| State Street and SPDR | For | Against * | For |
| American Century | For | Against * | For |
| Franklin Templeton | For | Against * | For |
| Invesco | For | Against * | For |
| Equitable | Against * | Against * | For |
| Charles Schwab | For | Against * | For |
| ProShares and ProFunds | For | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | No report | Against * | No report |
| J.P. Morgan | For | Against * | For |
| Goldman Sachs | For | Against * | For |
| WisdomTree | For | Against * | For |
| PGIM and Prudential | For | Against * | For |
| Jackson National funds | Against * | Against * | For |
| Northern Trust and FlexShares | For | Against * | For |
| SEI | No report | Against * | No report |
| T. Rowe Price | For | Against * | For |
| Lincoln Financial | Against | Against | For |
| First Trust | No report | Against * | No report |
| Nationwide | Against * | Against * | For |
| Brighthouse Funds | For | Against * | For |
| Guggenheim and Rydex | For | Against * | For |
| Columbia Threadneedle | No report | For | No report |
| BNY Mellon | No report | Against * | No report |
| Capital Group and American Funds | For | For | For |
| Global X | For | Against * | For |
| AllianceBernstein | No report | Against * | No report |
| MassMutual | For | Against * | For |
| Neuberger Berman | No report | Against * | No report |
| American Beacon | For | For | For |
| Natixis and Loomis Sayles | Against * | Against * | For |
| Baird | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the CRISPR THERAPEUTICS AG meeting?
516 Form N-PX filers reported votes at the meeting of 5 Jun 2025. On say-on-pay, 284 of 473 voted against management (60.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by CRISPR THERAPEUTICS AG on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for CRISPR THERAPEUTICS AG
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing CRISPR THERAPEUTICS AG with a meeting date within three days of 5 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.